273 related articles for article (PubMed ID: 22076761)
1. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and docking studies of novel antitumor benzimidazoles.
Omar MA; Shaker YM; Galal SA; Ali MM; Kerwin SM; Li J; Tokuda H; Ramadan RA; El Diwani HI
Bioorg Med Chem; 2012 Dec; 20(24):6989-7001. PubMed ID: 23123017
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives.
Nawrocka W; Sztuba B; Kowalska MW; Liszkiewicz H; Wietrzyk J; Nasulewicz A; Pełczyńska M; Opolski A
Farmaco; 2004 Feb; 59(2):83-91. PubMed ID: 14871499
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
5. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their cytotoxic activity against human cancer cell lines.
Karpińka MM; Matysiak J; Niewiadomy A
Arch Pharm Res; 2011 Oct; 34(10):1639-47. PubMed ID: 22076764
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
El-Nassan HB
Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
[TBL] [Abstract][Full Text] [Related]
8. Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity.
Solomon VR; Hu C; Lee H
Bioorg Med Chem; 2009 Nov; 17(21):7585-92. PubMed ID: 19804979
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives.
Gürsoy E; Güzeldemirci NU
Eur J Med Chem; 2007 Mar; 42(3):320-6. PubMed ID: 17145120
[TBL] [Abstract][Full Text] [Related]
12. Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins.
Freitas LAB; Sousa C; Lima BS; Duarte D; Gomes PATM; Ramos CGC; Costa VCM; Pitta MGDR; Rêgo MJBM; de Simone CA; Videira M; Leite ACL
Chem Biol Interact; 2024 May; 394():110954. PubMed ID: 38518852
[TBL] [Abstract][Full Text] [Related]
13. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
Abdul Rahim AS; Salhimi SM; Arumugam N; Pin LC; Yee NS; Muttiah NN; Keat WB; Abd Hamid S; Osman H; Mat Ib
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1255-60. PubMed ID: 23061895
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel Mannich bases of 2-arylimidazo[2,1-b]benzothiazoles as potential anti-cancer agents.
Kumbhare RM; Vijay Kumar K; Janaki Ramaiah M; Dadmal T; Pushpavalli SN; Mukhopadhyay D; Divya B; Anjana Devi T; Kosurkar U; Pal-Bhadra M
Eur J Med Chem; 2011 Sep; 46(9):4258-66. PubMed ID: 21775028
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, and docking studies of some fused-quinazolines and quinazolines carrying biological active isatin moiety as cell-cycle inhibitors of breast cancer cell lines.
Radwan AA; Alanazi FK; Al-Dhfyan A
Drug Res (Stuttg); 2013 Mar; 63(3):129-36. PubMed ID: 23444171
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor screening of novel 3-phenylthiazolo [4,5-d]pyrimidin-2-thione derivatives.
Becan L; Wagner E
Arzneimittelforschung; 2008; 58(10):521-8. PubMed ID: 19025063
[TBL] [Abstract][Full Text] [Related]
19. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates.
Havrylyuk D; Kovach N; Zimenkovsky B; Vasylenko O; Lesyk R
Arch Pharm (Weinheim); 2011 Aug; 344(8):514-22. PubMed ID: 21681810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
